Skip to main content

Roche news in 2026: 38 dated events

The latest Roche event on this page is dated Oct 28, 2026. globenewswire.com reported: Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma.

PublicPharmaceutical Manufacturing10,000+ employeesroche.comLinkedIn

Get Roche's live signals in Claude or ChatGPT, or by API

AskWhat changed at Roche this week? Use Autobound signals for roche.com.
Dated events
38
Last 90 days
31
Latest
Oct 28, 2026

Source: Autobound Signal API · 87 signals tracked for Roche · updated

News · latest 10

Latest Roche news

  1. Launch
    Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesotheliomaRoche has launched the VENTANA BAP1 (SP527) test, an automated immunohistochemistry diagnostic assay to identify mesothelioma.
  2. Certification
  3. Revenue
    [Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF...Roche reported Group sales of CHF 46.5 billion in the first nine months of 2026, an increase of 6% at constant exchange rates.
  4. Facility expansion
    Roche's new Mannheim calling cardRoche has opened a new 1,500-square-meter reception building, the Gatehouse, and an adjacent landscape park at its plant site in Mannheim, Germany.
  5. In development
    A daily pill to fight breast cancer? Swiss firm’s new drug completes 3 phases of human trialsF. Hoffmann-La Roche AG is seeking US approval for its breast cancer pill giredestrant following the completion of Phase III trials.
  6. Partnership
  7. In development
    Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolioRoche showcased Phase III clinical results for its cancer drug Divarasib in advanced lung cancer.
  8. Partnership
  9. Investment
  10. Launch
    Roche Gets FDA Approval for Another Label Expansion of TecentriqThe FDA approved Roche's Tecentriq and Tecentriq Hybreza in combination with chemotherapy for the adjuvant treatment of stage III dMMR colon cancer.

Showing 10 of 38 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Roche with the Signal API

One POST /v1/companies/enrich call with roche.com returns Roche news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"roche.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Roche news

What is the latest news on Roche?
The newest event on this page is dated Oct 28, 2026. globenewswire.com reported: Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma. This page lists 38 dated events for Roche, each with a source link.
What is going on with Roche?
The 10 latest events on this page cover launch (2), certification (1), revenue (1), facility expansion (1), in development (2), partnership (2) and investment (1). The newest: Oct 28, 2026: Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma (globenewswire.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →